The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agents

被引:22
作者
Powers, JH [1 ]
Ross, DB [1 ]
Brittain, E [1 ]
Albrecht, R [1 ]
Goldberger, MJ [1 ]
机构
[1] US FDA, Off Drug Evaluat 4, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
关键词
D O I
10.1086/339072
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:879 / 881
页数:3
相关论文
共 4 条
[1]   The United States Food and Drug Administration and the end of antibiotics [J].
Shlaes, DM ;
Moellering, RC .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (03) :420-422
[2]  
*US FDA DIV ANT IN, 1992, POINTS CONS CLIN DEV
[3]  
2002, INT C HARM STAT PRIN
[4]  
2002, INT C HARM CHOIC CON